Rosetta Genomics Ltd
OTC:ROSGQ
Rosetta Genomics Ltd
Total Liabilities
Rosetta Genomics Ltd
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Rosetta Genomics Ltd
OTC:ROSGQ
|
Total Liabilities
$7.5m
|
CAGR 3-Years
50%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Total Liabilities
$5.8m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Total Liabilities
$96.7m
|
CAGR 3-Years
49%
|
CAGR 5-Years
28%
|
CAGR 10-Years
7%
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Total Liabilities
$240.7m
|
CAGR 3-Years
126%
|
CAGR 5-Years
81%
|
CAGR 10-Years
N/A
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Total Liabilities
$1.4m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Total Liabilities
₪15.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
25%
|
See Also
What is Rosetta Genomics Ltd's Total Liabilities?
Total Liabilities
7.5m
USD
Based on the financial report for Dec 31, 2016, Rosetta Genomics Ltd's Total Liabilities amounts to 7.5m USD.
What is Rosetta Genomics Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
26%
Over the last year, the Total Liabilities growth was 169%. The average annual Total Liabilities growth rates for Rosetta Genomics Ltd have been 50% over the past three years , 26% over the past five years .